Actinium Pharmaceuticals (ATNM) Earnings Date & Reports

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ATNM is expected to report earnings to fall 130.34% to -27 cents per share on November 23

Actinium Pharmaceuticals ATNM Stock Earnings Reports

Q3'26

Est.

$-0.27

Q2'26

Beat

by $1.10

Q1'26

Missed

by $0.01

Q4'25

Missed

by $0.01

Q3'25

Beat

by $0.16

The last earnings report on August 24 showed earnings per share of 88 cents, beating the estimate of -20 cents. With 144.01K shares outstanding, the current market capitalization sits at 34.51M.

View a ticker or compare two or three

ATNM

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days